These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12366818)

  • 1. The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours.
    Chekenya M; Enger PØ; Thorsen F; Tysnes BB; Al-Sarraj S; Read TA; Furmanek T; Mahesparan R; Levine JM; Butt AM; Pilkington GJ; Bjerkvig R
    Neuropathol Appl Neurobiol; 2002 Oct; 28(5):367-80. PubMed ID: 12366818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NG2 precursor cells in neoplasia: functional, histogenesis and therapeutic implications for malignant brain tumours.
    Chekenya M; Pilkington GJ
    J Neurocytol; 2002; 31(6-7):507-21. PubMed ID: 14501220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets.
    Girolamo F; Dallatomasina A; Rizzi M; Errede M; Wälchli T; Mucignat MT; Frei K; Roncali L; Perris R; Virgintino D
    PLoS One; 2013; 8(12):e84883. PubMed ID: 24386429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NG2 expression regulates vascular morphology and function in human brain tumours.
    Brekke C; Lundervold A; Enger PØ; Brekken C; Stålsett E; Pedersen TB; Haraldseth O; Krüger PG; Bjerkvig R; Chekenya M
    Neuroimage; 2006 Feb; 29(3):965-76. PubMed ID: 16253523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NG2 Proteoglycan-Dependent Contributions of Pericytes and Macrophages to Brain Tumor Vascularization and Progression.
    Stallcup WB; You WK; Kucharova K; Cejudo-Martin P; Yotsumoto F
    Microcirculation; 2016 Feb; 23(2):122-33. PubMed ID: 26465118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NG2 proteoglycan promotes angiogenesis-dependent tumor growth in CNS by sequestering angiostatin.
    Chekenya M; Hjelstuen M; Enger PØ; Thorsen F; Jacob AL; Probst B; Haraldseth O; Pilkington G; Butt A; Levine JM; Bjerkvig R
    FASEB J; 2002 Apr; 16(6):586-8. PubMed ID: 11919162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma.
    Wang J; Svendsen A; Kmiecik J; Immervoll H; Skaftnesmo KO; Planagumà J; Reed RK; Bjerkvig R; Miletic H; Enger PØ; Rygh CB; Chekenya M
    PLoS One; 2011; 6(7):e23062. PubMed ID: 21829586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 adhesion molecule and neuro-glial proteoglycan NG2 as invasive markers of glioma.
    Wiranowska M; Ladd S; Smith SR; Gottschall PE
    Brain Cell Biol; 2006 Jun; 35(2-3):159-72. PubMed ID: 17957481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function.
    You WK; Yotsumoto F; Sakimura K; Adams RH; Stallcup WB
    Angiogenesis; 2014 Jan; 17(1):61-76. PubMed ID: 23925489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.
    Brand C; Schliemann C; Ring J; Kessler T; Bäumer S; Angenendt L; Mantke V; Ross R; Hintelmann H; Spieker T; Wardelmann E; Mesters RM; Berdel WE; Schwöppe C
    Oncotarget; 2016 Feb; 7(6):6774-89. PubMed ID: 26735180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the chondroitin sulphate proteoglycan, NG2, in paediatric brain tumors.
    Higgins SC; Bolteus AJ; Donovan LK; Hasegawa H; Doey L; Al Sarraj S; King A; Ashkan K; Roncaroli F; Fillmore HL; Pilkington GJ
    Anticancer Res; 2014 Dec; 34(12):6919-24. PubMed ID: 25503117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for the NG2 proteoglycan in glioma progression.
    Stallcup WB; Huang FJ
    Cell Adh Migr; 2008; 2(3):192-201. PubMed ID: 19262111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progenitor/Stem Cell Markers in Brain Adjacent to Glioblastoma: GD3 Ganglioside and NG2 Proteoglycan Expression.
    Lama G; Mangiola A; Proietti G; Colabianchi A; Angelucci C; D' Alessio A; De Bonis P; Geloso MC; Lauriola L; Binda E; Biamonte F; Giuffrida MG; Vescovi A; Sica G
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):134-47. PubMed ID: 26792897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous brain pericytes are widely activated and contribute to mouse glioma microvasculature.
    Svensson A; Özen I; Genové G; Paul G; Bengzon J
    PLoS One; 2015; 10(4):e0123553. PubMed ID: 25875288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NG2 Proteoglycan in Pericyte Biology.
    Stallcup WB
    Adv Exp Med Biol; 2018; 1109():5-19. PubMed ID: 30523586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferating NG2-Cell-Dependent Angiogenesis and Scar Formation Alter Axon Growth and Functional Recovery After Spinal Cord Injury in Mice.
    Hesp ZC; Yoseph RY; Suzuki R; Jukkola P; Wilson C; Nishiyama A; McTigue DM
    J Neurosci; 2018 Feb; 38(6):1366-1382. PubMed ID: 29279310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NG2 proteoglycan-binding peptides target tumor neovasculature.
    Burg MA; Pasqualini R; Arap W; Ruoslahti E; Stallcup WB
    Cancer Res; 1999 Jun; 59(12):2869-74. PubMed ID: 10383148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting pericytes diminishes neovascularization in orthotopic uveal melanoma in nerve/glial antigen 2 proteoglycan knockout mouse.
    Ozerdem U
    Ophthalmic Res; 2006; 38(5):251-4. PubMed ID: 16888406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma.
    Simonavicius N; Robertson D; Bax DA; Jones C; Huijbers IJ; Isacke CM
    Mod Pathol; 2008 Mar; 21(3):308-15. PubMed ID: 18192970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell-derived pericytic cells in brain tumor angio-architecture.
    Bababeygy SR; Cheshier SH; Hou LC; Higgins DM; Weissman IL; Tse VC
    Stem Cells Dev; 2008 Feb; 17(1):11-8. PubMed ID: 18240955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.